Company Name or Ticker Symbol
Search for other Categories
Dynasil Corp Of America  (DYSL)
Other Ticker:  
Price: $0.9900 $0.00 0.000%
Day's High: $1 Week Perf: -0.69 %
Day's Low: $ 0.98 30 Day Perf: -1.98 %
Volume (M): 2 52 Wk High: $ 1.60
Volume (M$): $ 2 52 Wk Avg: $1.13
Open: $0.98 52 Wk Low: $0.72

 Market Capitalization (Millions $) 17
 Shares Outstanding (Millions) 17
 Employees 230
 Revenues (TTM) (Millions $) 43
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 2

Dynasil Corp Of America

Dynasil Corporation of America was founded as a New Jersey corporation in 1960 and incorporated in the state of Delaware through a migratory merger in March 2008. Our corporate headquarters are located at 313 Washington Street, Suite 403, Newton, MA 02458, and our corporate website is www.dynasil.com.

We have three reporting segments based on our main operating activities, as well as a fourth segment substantially all of the assets of which were sold in the first quarter of 2014. Below is a summary of these segments:

Contract Research: The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (“RMD”) business unit, which is among the largest small business participants in U.S. government-funded research.

Optics: The Optics segment encompasses four business units – Dynasil Fused Silica, Optometrics, Hilger Crystals, and Evaporated Metal Films – that manufacture commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications.

Biomedical: The Biomedical segment consists of a single business unit, Dynasil Biomedical Corporation (“Dynasil Biomedical”), a medical technology incubator which owns rights to certain early stage medical technologies. In October 2013, Dynasil Biomedical formed Xcede Technologies, Inc. (“Xcede”), a joint venture with Mayo Clinic to spin out and separately fund the development of a tissue sealant technology. At September 30, 2015, Dynasil Biomedical owned 90% of the common stock of Xcede (approximately 69%, assuming conversion of the $2.0 million of the outstanding convertible notes), and therefore Xcede is included in our consolidated financial statements. Dynasil Biomedical currently has no operations other than relating to its equity ownership in Xcede.

Instruments: The Instruments segment consists of Dynasil Products (formerly known as RMD Instruments), which manufactured precision instrumentation for medical and commercial applications until the sale in fiscal 2014 of our lead paint detector and gamma medical probe businesses, which together comprised substantially all the operations within our Instruments segment.

DYSL is expected to report next financial results on August 12, 2019.

Dynasil Of America's Segments

American Resources Corporation

Logged a Loss, Sales Lower

In the first quarter American Resources Corporation lost money of $-0.48 per share compare to $-2.93 a year ago and increased losses from $-0.42 per share from the previous quarter.

Sales contracted by -4.52 % to $6.99 millions from $7.33 millions in the same quarter a year ago and sequentially Sales deteriorated by -14.06 % from $8.14 millions.

Kibush Capital Corp

Kibush Capital Corp announced second quarter operating deficit of $-0.135395 millions

In the second quarter Kibush Capital Corp reached break-even of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter.

Sales increased sharply by 176.39 % to $0.05 millions from $0.02 millions in the same quarter a year ago and sequentially Sales decreased by -0.37 % from $0.05 millions.

Protagenic Therapeutics, Inc.new

Protagenic Therapeutics, Inc.new announced first quarter operating deficit of $-0.654015 millions

In the first quarter Protagenic Therapeutics, Inc.new lost money of $-0.06 per share compare to $-0.06 a year ago and improved from $-0.08 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Digipath, Inc.

Digipath, Inc announced second quarter operating loss of $-0.455712 millions

Although company's Sales increased by 11.75 % from the same quarter a year ago to $0.65 millions in the second quarter, Digipath, Inc lost money at $-0.01 loss per share.

United Cannabis Corp

Redemption of Losses, Sales more than Double

United Cannabis Corp announced earnings per share of $-0.02 and Sales of $2.98 millions in the first quarter, Company's decreased loss per share, versus $-0.11 eps, earned in the same quarter a year ago, although United Cannabis Corp saw it's Sales rise by 1557.07 % in the same period.

Major Competitors Stock performance

5 Days Decrease / Increase
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

HBKA's Profile

Stock Price

HBKA's Financials

Business Description


Charts & Quotes

HBKA's News


HBKA's Competitors

Customers & Markets

Economic Indicators

HBKA's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071